An interaction between the inflammatory condition and the hypercoagulable condition occurs in primary Sjögren syndrome

[1]  F. Ferro,et al.  One year in review 2020: pathogenesis of primary Sjögren's syndrome. , 2020, Clinical and experimental rheumatology.

[2]  Wei Wang,et al.  Plasma fibrinogen, d-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis , 2020, Scientific Reports.

[3]  E. Reis,et al.  Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus , 2020, Lupus.

[4]  J. Eikelboom,et al.  A Test in Context: D-Dimer. , 2017, Journal of the American College of Cardiology.

[5]  Hyon K. Choi,et al.  The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study , 2017, The Journal of Rheumatology.

[6]  L. Criswell,et al.  2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts , 2017, Arthritis & rheumatology.

[7]  G. Baron,et al.  Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI) , 2014, Annals of the rheumatic diseases.

[8]  A. Marzano,et al.  Interactions between inflammation and coagulation in autoimmune and immune-mediated skin diseases. , 2012, Current vascular pharmacology.

[9]  Sreeram V Ramagopalan,et al.  Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study , 2011, BMC medicine.

[10]  G. Illei,et al.  Cytokines in Sjögren's syndrome. , 2009, Oral diseases.

[11]  G. Baron,et al.  EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome , 2009, Annals of the rheumatic diseases.

[12]  B. Rovin,et al.  D-dimer level and the risk for thrombosis in systemic lupus erythematosus. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[13]  E. Cadman,et al.  Sjögren's Syndrome , 1953, Medicine illustrated.

[14]  G. Hensing,et al.  A general population-based study , 2006 .